A 32 year old high altitude mountaineer is observed to have a hematocrit of 70 percent. Which of the following represents the most likely cause/explanation
First, I need to recall the physiological adaptations to high altitude. High altitude means lower oxygen levels, so the body responds by increasing red blood cell production to improve oxygen delivery. This is through the release of erythropoietin (EPO) from the kidneys. Erythropoiesis increases, leading to higher hematocrit. That makes sense. So the core concept here is hypoxia-induced erythrocytosis.
Now, the options aren't provided, but the correct answer is likely related to this mechanism. Let's assume the options are something like: A. Dehydration, B. Primary polycythemia, C. Secondary polycythemia due to high altitude, D. Sickle cell disease.
Wait, the correct answer would be secondary polycythemia due to high altitude. So why is that the case? Because the body is compensating for hypoxia by making more RBCs. The hematocrit is elevated as a result of increased RBC mass.
For the incorrect options: Dehydration would cause hemoconcentration, but hematocrit would go up temporarily. However, in a mountaineer, the high hematocrit is more likely due to chronic adaptation, not acute dehydration. Primary polycythemia (like polycythemia vera) is a myeloproliferative disorder, but that's less likely in a young, otherwise healthy mountaineer. Sickle cell is a genetic condition and wouldn't be caused by altitude.
Clinical pearl: Remember that secondary polycythemia in altitude is a compensatory mechanism with normal oxygen saturation. In contrast, primary polycythemia has normal oxygen levels but increased RBC production due to EPO-independent factors.
**Core Concept**
High-altitude hypoxia triggers **erythropoietin (EPO)-mediated erythrocytosis**, increasing red blood cell mass to enhance oxygen delivery. This is a classic adaptive response to chronic hypoxia, not a pathological condition.
**Why the Correct Answer is Right**
At high altitude, reduced atmospheric oxygen lowers alveolar oxygen tension, stimulating **hypoxia-inducible factor (HIF)**. This activates renal **erythropoietin (EPO) release**, which stimulates **erythroid progenitor cells** in the bone marrow. Over weeks, this leads to increased red blood cell production and elevated hematocrit (e.g., 70%), improving oxygen-carrying capacity in hypoxic environments.
**Why Each Wrong Option is Incorrect**
**Option A:** *Dehydration* causes hemoconcentration but would not explain a sustained hematocrit of 70% in a mountaineer with adequate hydration.
**Option B:** *Polycythemia vera* is a myeloproliferative disorder with normal oxygen saturation and elevated EPO levels, but it is unrelated to altitude.
**Option D:** *Sickle cell trait* is a genetic condition causing abnormal hemoglobin, not a compensatory response to hypoxia.
**Clinical Pearl / High-Yield Fact**
Differentiate **secondary polycythemia** (altitude, COPD,